论文部分内容阅读
１引言 自我国首创的全反式维Ａ酸（ＡＴＲＡ）诱导治疗急性早幼粒细胞白血病（Ｍ３）以来，该病的缓解率明显提高，完全缓解率达８０％至９０％［１］，但完全缓解后用哪一种巩固维持治疗方案各家意见不一，也是目前研究的要点。为总结经验，我们对７２例经ＡＴＲＡ诱导完全缓
1 Introduction Since the induction of acute promyelocytic leukemia (M3) induced by all-trans-retinoic acid (ATRA) first pioneered by our country, the remission rate of this disease has been significantly improved, with a complete remission rate of 80% to 90% [1]. Various opinions on consolidating maintenance treatment programs after complete remission are also the main points of current research. In order to sum up experience, we completely relaxed 72 cases induced by ATRA.